N-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Metabolism Reviews
- Vol. 34 (3), 651-665
- https://doi.org/10.1081/dmr-120005667
Abstract
Circumstantial evidence strongly suggests that most idiosyncratic drug reactions are due to reactive metabolites of drugs rather than due to the drugs themselves. Many of the drugs that are associated with idiosyncratic drug reactions contain nitrogen. There are many possible reasons for this association. One is simply that many drugs, especially CNS active drugs, contain nitrogen. In addition, nitrogen is relatively easy to oxidize because of its lone pair of electrons and many nitrogen-containing compounds readily undergo redox cycling, which can generate reactive oxygen species. There are several nitrogen-containing function groups that are especially associated with adverse reactions. These include aromatic amines, nitro compounds (nitro compounds are reduced to the same reactive intermediates as are formed by oxidation of the corresponding aromatic amine), hydrazines and compounds that can be oxidized to iminoquinone and related compounds. A greater attention to the issue of reactive metabolites during drug development would likely lead to safer drugs; however, not all drugs that form reactive metabolites are associated with a high incidence of idiosyncratic drug reactions. In addition to the presence of such a group, other factors, such as dose and electron density of the compound, appear to play a role in whether the drug containing such functional groups will be associated with a relatively high incidence of idiosyncratic drug reactions.Keywords
This publication has 35 references indexed in Scilit:
- Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?Drug Safety, 2001
- New Concepts in Immunology Relevant to Idiosyncratic Drug Reactions: The “Danger Hypothesis” and Innate Immune SystemChemical Research in Toxicology, 1999
- HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.JCI Insight, 1998
- Reactive intermediates in the oxidation of hydralazine by HOCl: the major oxidant generated by neutrophilsChemico-Biological Interactions, 1993
- Clinical profile of clozapine: Adverse reactions and agranulocytosisPsychiatric Quarterly, 1992
- Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.JCI Insight, 1988
- The Immunologic and Metabolic Basis of Drug HypersensitivitiesAnnual Review of Pharmacology and Toxicology, 1988
- The Role of Metabolite-Specific Antibodies in Nomifensine-Dependent Immune Hemolytic AnemiaThe New England Journal of Medicine, 1985
- Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants.JCI Insight, 1985
- Reply to Dr. Knyvett's CommentAustralian and New Zealand Journal of Medicine, 1972